Iovance Biotherapeutics, Inc. (IOVA) key performance indicators and operating metrics (6 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Global Proleukin revenue | 11M | FY2026-Q1 |
| United States Amtagvi Revenue | 60M | FY2026-Q1 |
| Authorized Treatment Centers | 90.00 | FY2026-Q1 |
| Total Product Revenue | 87M | FY2025-Q4 |
| Proleukin Revenue | 5.9M | FY2025-Q2 |
| Amtagvi Revenue | 54.1M | FY2025-Q2 |
Back to IOVA overview · IOVA earnings · IOVA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.